National Guideline Clearinghouse | Bevacizumab in combination with capecitabine for the first-line treatment of metastatic breast cancer.
Guideline Title
Bevacizumab in combination with capecitabine for the first-line treatment of metastatic breast cancer.
Bibliographic Source(s)
National Institute for Health and Clinical Excellence (NICE). Bevacizumab in combination with capecitabine for the first-line treatment of metastatic breast cancer. London (UK): National Institute for Health and Clinical Excellence (NICE); 2012 Aug. 48 p. (Technology appraisal guidance; no. 263). |
Guideline Status
This is the current release of the guideline.
No hay comentarios:
Publicar un comentario